Back to Trials
NCT03667599NARecruiting

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Duke University

Start Date

9/28/2018

Completion Date

1/30/2027

Summary

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

Eligibility Criteria

Age Range: 18 years to 80 years

Patient Inclusion Criteria: * Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness * Age 18-80 years * Karnofsky Performance Scale KPS\> 80 * Able to read/write English * A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke Patient Exclusion Criteria: * Lack of a caregiver * Pregnant women * Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection. * Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota Caregiver Inclusion Criteria: * Identified by patient as their primary caregiver * Meet standard clinical criteria for being a caregiver (able to drive and take care of patient) * Age 18-80 years Caregiver Exclusion Criteria: None

Interventions

OTHER

home care

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Well-being of Caregivers (Caregiver Strain Index)

Locations

Duke University Medical Center

Durham, North Carolina 27705

United States